Saturday, September 5, 2026

From X

IAC · long

Iac INC

IAC is simplifying its portfolio around a 33% stake in MGM Resorts International, positioning the holding company for a later-stage…

Sarepta Risk and the FDA

Sarepta’s Exondys 51 approval despite a 12-patient trial frames FDA regulatory risk and a call to remove Commissioner Robert Califf.

Publications we follow

Every publication on this site, hand-picked.

69 publications

X accounts we follow

Every account on this site, hand-picked.

55 accounts

Sectors

Ordered by how often our editor reaches for them.